Cited by 30Suicide and Self-Harm StudiesTryptophan and brain disordersTreatment of Major Depression

A probe in the connection between inflammation, cognition and suicide

Open access
Cáceda, Ricardo, Griffin, W Sue T, Delgado, Pedro L·2018·Journal of Psychopharmacology

Abstract

Background: Increased inflammation is linked to suicide risk. However, it is unclear whether increased inflammation drives suicidal crises or is a trait associated with lifetime suicidal behavior. Limited data exist on the sources of increased inflammation observed in suicidal patients and on its downstream effects. Aims: To examine factors associated with inflammation and with suicidal ideation severity in acutely suicidal depressed patients. Methods: Fifty-two adult depressed patients of both sexes hospitalized for severe suicidal ideation were characterized for suicidality, depression, anxiety, medical comorbidity, psychological and physical pain, impulsivity, verbal fluency, C-reactive protein (CRP) and interleukin (IL) 6. Two generalized linear models were performed with either CRP or suicidal ideation severity as dependent variables. Results: CRP levels were positively associated with age, body mass index (BMI), IL6, current physical pain and number of lifetime suicide attempts. Suicidal ideation severity was not significantly correlated with either CRP or IL6. Suicidal ideation severity was positively associated with female sex, presence of an anxiety disorder, current physical pain, number of lifetime suicide attempts and with delay discounting for medium and large losses. Conclusions: Increased inflammation is not associated with acute suicidal risk, but seems to represent a trait associated with lifetime suicidal behavior.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/0269881118764022

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Peripheral inflammatory biomarkers linked to suicide risk include elevated CRP, neutrophil-to-lymphocyte ratio, proinflammatory interleukins, cytokines such as IL-1β and IL-6, TNF-α, TGF-β1, and VEGF, and low levels of anti-inflammatory IL-2, IL-4, and IFN-γ in suicidal individuals.

    “Peripheral inflammatory biomarkers linked to suicide risk include elevated C-reactive protein (CRP), neutrophil-to-lymphocyte ratio, proinflammatory interleukins (IL), cytokines that regulate the immune response (e.g., IL-1β and IL-6), tumor necrosis factor-α (TNF-α), tissue growth factor-β1 (TGF-β1), and vascular endothelial growth factor (VEGF) and low levels of the anti-inflammatory IL-2, IL-4,”

    From A brain-centric model of suicidal behavior (2020) · cites this paper as [196]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cáceda, R., Griffin, W. S. T., & Delgado, P. L.
Affiliations
  • Stony Brook University (US)
  • Central Arkansas Veterans Healthcare System (US)
  • University of Arkansas for Medical Sciences (US)
Corresponding author
Cáceda, Ricardo
Venue
Journal of Psychopharmacology
Published
2018-03-19
Volume
32
Issue
4
Pages
482-488
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W2791661868
Cited by
30
References
57
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 3 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 4
FWCI
6.17
Type
journal article
Language
en
Open access
Locations
  • Journal of Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Aging (AG12411)
  • Clinician Scientist Program of the University Arkansas for Medical Sciences (205-2017)
  • National Center for Advancing Translational Sciences (UL1TR000039)
  • National Institute of General Medical Sciences (P30 GM110702)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
inflammation, suicide, suicidal ideation, C-reactive protein, interleukin-6, depression, anxiety disorders, bodily pain, delay discounting, impulsivity, lifetime suicide attempts, cognitive function, verbal fluency
MeSH terms
Adolescent, Adult, Anxiety Disorders, Depression, Depressive Disorder, Female, Humans, Impulsive Behavior, Inflammation, Male, Middle Aged, Risk Factors, Suicide, Attempted, Young Adult, Suicidal Ideation, Delay Discounting

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review